Monoamine oxidase inhibitor

Results: 66



#Item
41Phendimetrazine Tartate Label

Phendimetrazine Tartate Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-02-24 10:24:15
42

PDF Document

Add to Reading List

Source URL: www.ciel.org

Language: English - Date: 2011-11-10 17:11:44
43COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capitol Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601

COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capitol Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-08-21 19:34:47
44HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIIBRYD safely and effectively. See full prescribing information for VIIBRYD. VIIBRYD (vilazodone HCl) Tablets

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIIBRYD safely and effectively. See full prescribing information for VIIBRYD. VIIBRYD (vilazodone HCl) Tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-10 13:32:35
45COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capitol Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601

COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capitol Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-08-21 16:44:05
461 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (duloxetine hydrochloride

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (duloxetine hydrochloride

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-10-22 15:47:58
47not start PRISTIQ in a patient who is being treated with linezolid or intravenous methylene blue[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRISTIQ safe

not start PRISTIQ in a patient who is being treated with linezolid or intravenous methylene blue[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRISTIQ safe

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-12-24 13:42:11
48HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AZILECT® safely and effectively. See full prescribing information for AZILECT. AZILECT (rasagiline mesylate) Tablet

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AZILECT® safely and effectively. See full prescribing information for AZILECT. AZILECT (rasagiline mesylate) Tablet

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-06-03 15:28:27
49SAVELLA (milnacipran HCl) Tablets

SAVELLA (milnacipran HCl) Tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-12-07 11:39:21
50Marplan® (isocarboxazid) Tablets :: May help when your major depression symptoms resist standard treatments. :: Professionals :: Clinical-trials  Please See Important Safety Information, Including Boxed Warning, Below P

Marplan® (isocarboxazid) Tablets :: May help when your major depression symptoms resist standard treatments. :: Professionals :: Clinical-trials Please See Important Safety Information, Including Boxed Warning, Below P

Add to Reading List

Source URL: www.fda.gov

Language: English